![]() |
MORPHOSYS AG O.N. |
ISIN | DE0006632003 |
Security | MOR |
Exchange | EUREX |
Type | Option |
Options
Exp. date | Type | Type |
---|---|---|
12/19 | 53 Calls | 52 Puts |
1/20 | 16 Calls | 16 Puts |
2/20 | 15 Calls | 15 Puts |
3/20 | 17 Calls | 16 Puts |
6/20 | 21 Calls | 21 Puts |
9/20 | 12 Calls | 12 Puts |
12/20 | 20 Calls | 20 Puts |
6/21 | 12 Calls | 12 Puts |
12/21 | 15 Calls | 15 Puts |
6/22 | 10 Calls | 10 Puts |
12/22 | 11 Calls | 11 Puts |
12/23 | 10 Calls | 10 Puts |
News
- MOR106 clinical development in atopic dermatitis stopped for futility
10/28/2019 / 21:45 - GlobeNewswire - Galapagos and MorphoSys announce initiation of GECKO Phase 2 study with MOR106 in atopic dermatitis patients
04/23/2019 / 22:02 - GlobeNewswire - Galapagos and MorphoSys announce initiation of GECKO Phase 2 study with MOR106 in atopic dermatitis patients
04/23/2019 / 22:01 - GlobeNewswire - Galapagos and MorphoSys announce start of a Phase 1 subcutaneous bridging study with MOR106
09/13/2018 / 22:04 - GlobeNewswire - Galapagos and MorphoSys announce start of a Phase 1 subcutaneous bridging study with MOR106
09/13/2018 / 22:01 - GlobeNewswire